Physician profile
David B Stein
NPI 1366409302
$14,734.46
in general payments reported to CMS, 2019-2025
63 companies · $1,873 in 2025
The $1,873 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,913 · 2020: $1,550 · 2021: $2,000 · 2022: $2,631 · 2023: $2,389 · 2024: $2,377 · 2025: $1,873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,633 · Education: $6.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,632.84 |
| Education | $6.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,517.86 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,445.57 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals Lp | $1,235.33 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $1,132.35 | 2019-2025 | |
| Lilly USA, LLC | $960.30 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $854.85 | 2019-2025 | Otezla, Repatha, Prolia |
| Amarin Pharma, INC. | $682.23 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $612.23 | 2019-2025 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $506.01 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Takeda Pharmaceuticals U.S.A., INC. | $441.04 | 2019-2025 | Trintellix |
| Abbott Laboratories | $396.95 | 2021-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $345.07 | 2019-2025 | Tradjenta, Jardiance |
| Teva Pharmaceuticals USA, INC. | $331.83 | 2019-2025 | Austedo Xr, Ajovy, Austedo |
| Novartis Pharmaceuticals Corporation | $307.82 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $287.79 | 2021-2025 |
Show all 63 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.